- Medical School - Tabriz University (2002-2008)
- Residency - St. Agnes Hospital (2014-2017), Internal Medicine
- Fellowship - Baylor College of Medicine (2017-2020), Hematology Oncology
- Fellowship - University of Texas MD Anderson Cancer Center (2020-2021), Stem Cell Transplantation & Cellular Therapy
Aimaz Afrough, M.D.
- Internal Medicine - Hematology/Oncology
- Plasma cell disorders
- Stem cell transplantation
Aimaz Afrough, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in multiple myeloma and other plasma cell dyscrasias, developing cellular therapy such as CAR T-cells with or without transplant, and immunotherapy.
Dr. Afrough earned her medical degree at Tabriz University of Medical Sciences in Iran and completed a residency in internal medicine at St. Agnes Hospital in Baltimore. She received advanced training through a hematology and oncology fellowship at Baylor College of Medicine and a stem cell transplantation and cellular therapy fellowship at the University of Texas MD Anderson Cancer Center.
Certified by the American Board of Internal Medicine in medical oncology and hematology, she joined the UT Southwestern faculty in 2021.
Dr. Afrough’s clinical research is focused on improving the therapy and outcome of patients with plasma cell disorders. She is particularly interested in developing novel therapeutic approaches, including adoptive cell therapy to improve the safety and efficacy of therapies in patients with these disorders. She has published numerous academic articles and delivered multiple presentations.
She is a member of several professional associations, including the American Society of Clinical Oncology, the American Society of Hematology, the American Society for Transplantation and Cellular Therapy, and the International Myeloma Society.
In 2019, Dr. Afrough received the Cancer Prevention and Research Institute of Texas (CPRIT) Training Award from the Baylor College of Medicine Comprehensive Cancer Training Program.
- American Society of Clinical Oncology
- American Society of Hematology
- American Society for Transplantation and Cellular Therapy
- International Myeloma Society
- Society of Hematologic Oncology
- ASCO Reviewer Mentoring Program 2020, Section of JCO Global Oncology
- Certificate of Added Qualification in Clinical Investigation 2020, Baylor College of Medicine Clinical Scientist Training Program
- CPRIT Training Award 2019, Baylor College of Medicine Comprehensive Cancer Training Program
- Travel Fellowship Award 2014, XIVth International Symposium on Amyloidosis
HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
Ghobadi A, Milton DR, Gowda L, Rondon G, Chemaly RF, Hamdi A, Alousi A, Afrough A, Oran B, Ciurea S, Kebriaei P, Popat UR, Qazilbash MH, Shpall EJ, Champlin RE, Bashir Q, Current research in translational medicine 2019 05 67 2 51-55
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation.
Afrough A, Saliba RM, Hamdi A, Honhar M, Varma A, Cornelison AM, Rondon G, Parmar S, Shah ND, Bashir Q, Hosing C, Popat U, Weber DM, Thomas S, Orlowski RZ, Champlin RE, Qazilbash MH, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018 11 24 11 2197-2203
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Varma A, Biritxinaga L, Saliba RM, Stich M, Jauch SF, Afrough A, Honhar M, Popat UR, Shafi MA, Shah N, Bashir Q, Dinh Y, Hosing C, Champlin RE, Qazilbash MH, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2017 Apr 23 4 581-587
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.
Abudayyeh A, Hamdi A, Abdelrahim M, Lin H, Page VD, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Oran B, Chemaly RF, Ahmed S, Abudayyeh I, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Rezvani K, Transplant infectious disease : an official journal of the Transplantation Society 2017 Feb 19 1
Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation.
Varma A, Saliba RM, Torres HA, Afrough A, Hosing C, Khouri IF, Nieto Y, Shah ND, Parmar S, Bashir Q, Ahmed S, Jones RB, Kebriaei P, Olson AL, Shpall EJ, Alousi AM, Qazilbash MH, Champlin RE, Popat U, Bone marrow transplantation 2016 07 51 7 999-1001
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients.
Abudayyeh A, Hamdi A, Lin H, Abdelrahim M, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Salahudeen A, Oran B, Chemaly RF, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Winkelmayer WC, Rezvani K, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2016 05 16 5 1492-502
Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement.
Cornelison AM, Saliba RM, Afrough A, Dinh Y, Nieto Y, Bashir Q, Shah N, Parmar S, Hosing C, Popat U, Shpall E, Champlin R, Qazilbash MH, Bone marrow transplantation 2016 Feb 51 2 307-9
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.
Afrough A, Saliba RM, Hamdi A, El Fakih R, Varma A, Dinh YT, Rondon G, Cornelison AM, Shah ND, Bashir Q, Shah JJ, Hosing C, Popat U, Orlowski RZ, Champlin RE, Parmar S, Qazilbash MH, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2015 Aug 21 8 1413-7
Donor cell-derived myelodysplastic syndrome with ring chromosome 7 after allogeneic hematopoietic stem cell transplant in 2 patients with lymphomas as primary disease.
Hamdi A, Afrough A, Muzzafar T, Popat UR, Hosing CM, Qazilbash MH, Lu G, Clinical lymphoma, myeloma & leukemia 2014 Oct 14 5 e151-5
Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Hamdi A, Mawad R, Bassett R, di Stasi A, Ferro R, Afrough A, Ram R, Dabaja B, Rondon G, Champlin R, Sandmaier BM, Doney K, Bar M, Kebriaei P, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2014 Nov 20 11 1767-71
Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.
Elsayegh N, Kuerer HM, Lin H, Gutierrez Barrera AM, Jackson M, Muse KI, Litton JK, Albarracin C, Afrough A, Hortobagyi GN, Arun BK, Annals of surgical oncology 2014 Oct 21 11 3466-72
- HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
- Developing Cellular Therapy such as CAR T Cells With or Without Transplant
- High-risk Multiple Myeloma
- Multiple Myeloma and other Plasma Cell Dyscrasia
- Plasma cell disorders
- Stem cell transplantation
Results: 1 Locations